To identify the underlying target molecules regulated by gemcitabine in HCC aerobic glycolysis, we analyzed LDHA, NDRG2 and c-Myc in HepG2 cells that were treated with gemcitabine at different concentrations. The gene discussed is LDHA; the disease is hepatocellular carcinoma.